↓ Skip to main content

Cochrane Database of Systematic Reviews

Best first‐line therapy for people with advanced non‐small cell lung cancer, performance status 2 without a targetable mutation or with an unknown mutation status

Overview of attention for article published in Cochrane database of systematic reviews, July 2023
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

blogs
1 blog
twitter
10 X users
wikipedia
2 Wikipedia pages
reddit
2 Redditors

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
28 Mendeley
Title
Best first‐line therapy for people with advanced non‐small cell lung cancer, performance status 2 without a targetable mutation or with an unknown mutation status
Published in
Cochrane database of systematic reviews, July 2023
DOI 10.1002/14651858.cd013382.pub2
Pubmed ID
Authors

Rolof Gp Gijtenbeek, Kim de Jong, Ben Jw Venmans, Femke Hm van Vollenhoven, Anneke Ten Brinke, Anthonie J Van der Wekken, Wouter H van Geffen

X Demographics

X Demographics

The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 28 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 28 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 8 29%
Other 1 4%
Lecturer 1 4%
Student > Ph. D. Student 1 4%
Student > Master 1 4%
Other 1 4%
Unknown 15 54%
Readers by discipline Count As %
Unspecified 8 29%
Nursing and Health Professions 3 11%
Medicine and Dentistry 1 4%
Unknown 16 57%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 December 2023.
All research outputs
#2,166,657
of 25,746,891 outputs
Outputs from Cochrane database of systematic reviews
#4,503
of 13,136 outputs
Outputs of similar age
#39,017
of 370,227 outputs
Outputs of similar age from Cochrane database of systematic reviews
#44
of 134 outputs
Altmetric has tracked 25,746,891 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,136 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.9. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 370,227 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 134 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.